0.8013
Bone Biologics Corp (BBLG) 最新ニュース
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BB - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split - Investing.com India
Bone Biologics Finalizes 1-for-6 Reverse Split: Key Details for Nasdaq Biotech Investors - Stock Titan
Bone Biologics (NASDAQ:BBLG) Trading Down 2.4% – What’s Next? - Defense World
Bone Biologics shareholders approve key proposals By Investing.com - Investing.com Canada
Bone Biologics shareholders approve key proposals - Investing.com
Global and China Osteoporosis Drugs Market Detailed in New Research ReportAmgen, Eli Lilly - openPR.com
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - The Globe and Mail
Bone Biologics (OTC:BBLG) Shares Up 18.5% – Time to Buy? - Defense World
TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR - Longview News-Journal
(BBLGW) Proactive Strategies - news.stocktradersdaily.com
WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering - Barchart.com
Zacks Small Cap Forecasts Bone Biologics Q2 Earnings - Defense World
Bone Biologics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Trend Tracker for (BBLGW) - news.stocktradersdaily.com
Orthobiologics Market Grows Strong with Expanding Use in Sports - openPR.com
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Revolutionary BMP Super-Agonists: Darnatein's New Biologics Promise Breakthrough in Bone and Cartilage Repair - Stock Titan
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
Bone Biologics (OTC:BBLG) Trading Down 0.4% – Should You Sell? - Defense World
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine - Equitypandit
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
TETROUS®, INC. SIGNS NEW DISTRIBUTION AGREEMENT IN NEW ZEALAND TO EXPAND PRESENCE IN THE ASIA-PACIFIC MARKET AND ADDS DR. CRAIG BALL TO IT'S SURGEON ADVISORY BOARD - PR Newswire
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA - Yahoo Finance
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
大文字化:
|
ボリューム (24 時間):